Query: Emerging technologies for high-content analysis of contractile function in cultured human myotubes: integration of calcium transient assays with microfabricated elastic substrates or optogenetic stimulation, quantification of contractile force, throughput considerations, and assay reproducibility in aged muscle cells

Emerging technologies for high-content analysis of contractile function in cultured human myotubes combine several innovative strategies that address the need for quantitative, reproducible, and high-throughput assays. Central to these approaches is the integration of calcium transient assays with microfabricated elastic substrates or optogenetic stimulation techniques. In this context, calcium transient assays—which monitor intracellular calcium dynamics as an immediate readout of excitation–contraction coupling—are combined with substrates engineered to measure mechanical contractile force. This integration allows researchers to correlate electrical activity (indicated by calcium signaling) with physical contraction, providing a comprehensive functional profile of the myotubes (osaki2020onchip3dneuromuscular pages 7-8, vesgacastro2024developmentofan pages 13-14).

Microfabricated elastic substrates, such as those produced from PDMS (polydimethylsiloxane) with precisely defined geometries, are deployed to align myotubes and quantify contractile force via substrate deformations. When myotubes contract, deflections or wrinkles in these substrates serve as quantitative metrics of force generation. Techniques using micropatterned grooves have been optimized—using specific dimensions such as 100 μm width and 700 μm length ratios—to ensure myotube alignment and maturation, which helps reduce variability in contractile force measurements (vesgacastro2024developmentofan pages 1-3, vesgacastro2024developmentofan pages 3-4). This method not only enhances the reproducibility of measurements but also supports high-content imaging of both contractile events and calcium transients.

Optogenetic stimulation offers an alternative or complementary approach to electrical stimulation. By using channelrhodopsin or similar light-activated ion channels expressed in myotubes or their innervating motor neurons, researchers can achieve precise spatiotemporal control of muscle activation. This reduces the need for invasive electrode insertion, minimizes contamination risk, and improves stimulation uniformity across multicellular constructs. Optogenetic setups can synchronize stimulation with calcium imaging and contractile force measurements, thereby allowing the direct correlation of induced excitations with mechanical outputs (osaki2020onchip3dneuromuscular pages 6-7, vesgacastro2024developmentofan pages 13-14).

Quantification of contractile force in these emerging platforms often relies on computational image analysis of substrate deformations. Techniques such as video capture combined with edge detection algorithms allow the conversion of observed deformations into measurable force outputs. Some platforms incorporate microcantilever arrays that directly transduce muscle contraction into quantifiable deflections, calibrated against known forces for accuracy. This method has been validated by its ability to capture different contraction patterns—ranging from synchronized and delayed signals to low amplitude and undershoot responses—which is crucial for distinguishing between healthy and pathological states (osaki2020onchip3dneuromuscular pages 26-27, thavandiran2019designofhuman pages 112-118).

Throughput is a major consideration in designing these assays. By adapting microfabricated substrates to multiwell formats (e.g., 96-well plates) and integrating automated imaging systems and liquid handling, the platforms support moderate to high throughput screening. These adaptations not only accelerate drug screening but also facilitate scalability for large-scale studies. Microfluidic compartmentalization and automated stimulation protocols further ensure that treatments can be tested in parallel under statistically robust conditions (thavandiran2019designofhuman pages 118-127, thavandiran2019designofhuman pages 127-139).

Assay reproducibility, particularly in the context of aged muscle cells, is enhanced by standardized patterning and controlled culture conditions that mitigate morphological heterogeneity. This is crucial when dealing with aged or diseased myotubes, which generally exhibit higher variability in contractile behavior. Incorporating iPSC-derived models and patient-specific cells helps recapitulate aging phenotypes, allowing these platforms not only to screen pharmacological candidates effectively but also to study the underlying mechanisms of contractile decline in aged muscle tissue (osaki2020onchip3dneuromuscular pages 26-27, vesgacastro2024developmentofan pages 11-12).

In summary, by merging calcium transient assays with microfabricated elastic substrates and optogenetic stimulation, these emerging technologies provide high-content, reliable, and scalable platforms for evaluating contractile function in human myotubes. Their design directly addresses challenges related to quantification, throughput, and assay reproducibility, which are essential for advancing drug screening and precision medicine in neuromuscular disease and aging research (osaki2020onchip3dneuromuscular pages 6-7, thavandiran2019designofhuman pages 166-177).

References:
1. (osaki2020onchip3dneuromuscular pages 26-27): Tatsuya Osaki, Sebastien G. M. Uzel, and Roger D. Kamm. On-chip 3d neuromuscular model for drug screening and precision medicine in neuromuscular disease. Nature Protocols, 15:421-449, Jan 2020. URL: https://doi.org/10.1038/s41596-019-0248-1, doi:10.1038/s41596-019-0248-1. This article has 132 citations and is from a peer-reviewed journal.

2. (osaki2020onchip3dneuromuscular pages 6-7): Tatsuya Osaki, Sebastien G. M. Uzel, and Roger D. Kamm. On-chip 3d neuromuscular model for drug screening and precision medicine in neuromuscular disease. Nature Protocols, 15:421-449, Jan 2020. URL: https://doi.org/10.1038/s41596-019-0248-1, doi:10.1038/s41596-019-0248-1. This article has 132 citations and is from a peer-reviewed journal.

3. (osaki2020onchip3dneuromuscular pages 7-8): Tatsuya Osaki, Sebastien G. M. Uzel, and Roger D. Kamm. On-chip 3d neuromuscular model for drug screening and precision medicine in neuromuscular disease. Nature Protocols, 15:421-449, Jan 2020. URL: https://doi.org/10.1038/s41596-019-0248-1, doi:10.1038/s41596-019-0248-1. This article has 132 citations and is from a peer-reviewed journal.

4. (thavandiran2019designofhuman pages 166-177): N Thavandiran. Design of human pluripotent stem cell-derived cardiac microtissue-based platforms for functional screening. Unknown journal, 2019.

5. (vesgacastro2024developmentofan pages 1-3): Camila Vesga-Castro, Laura Mosqueira-Martín, Paul Ubiria-Urkola, Pablo Marco-Moreno, Klaudia González-Imaz, Jorge Rendon-Hinestroza, Ainara Vallejo-Illarramendi, and Jacobo Paredes. Development of an <i>in vitro</i> platform for the analysis of contractile and calcium dynamics in single human myotubes. Lab on a Chip, 24:4741-4754, Jan 2024. URL: https://doi.org/10.1039/d3lc00442b, doi:10.1039/d3lc00442b. This article has 2 citations and is from a domain leading peer-reviewed journal.

6. (vesgacastro2024developmentofan pages 11-12): Camila Vesga-Castro, Laura Mosqueira-Martín, Paul Ubiria-Urkola, Pablo Marco-Moreno, Klaudia González-Imaz, Jorge Rendon-Hinestroza, Ainara Vallejo-Illarramendi, and Jacobo Paredes. Development of an <i>in vitro</i> platform for the analysis of contractile and calcium dynamics in single human myotubes. Lab on a Chip, 24:4741-4754, Jan 2024. URL: https://doi.org/10.1039/d3lc00442b, doi:10.1039/d3lc00442b. This article has 2 citations and is from a domain leading peer-reviewed journal.

7. (vesgacastro2024developmentofan pages 13-14): Camila Vesga-Castro, Laura Mosqueira-Martín, Paul Ubiria-Urkola, Pablo Marco-Moreno, Klaudia González-Imaz, Jorge Rendon-Hinestroza, Ainara Vallejo-Illarramendi, and Jacobo Paredes. Development of an <i>in vitro</i> platform for the analysis of contractile and calcium dynamics in single human myotubes. Lab on a Chip, 24:4741-4754, Jan 2024. URL: https://doi.org/10.1039/d3lc00442b, doi:10.1039/d3lc00442b. This article has 2 citations and is from a domain leading peer-reviewed journal.

8. (vesgacastro2024developmentofan pages 3-4): Camila Vesga-Castro, Laura Mosqueira-Martín, Paul Ubiria-Urkola, Pablo Marco-Moreno, Klaudia González-Imaz, Jorge Rendon-Hinestroza, Ainara Vallejo-Illarramendi, and Jacobo Paredes. Development of an <i>in vitro</i> platform for the analysis of contractile and calcium dynamics in single human myotubes. Lab on a Chip, 24:4741-4754, Jan 2024. URL: https://doi.org/10.1039/d3lc00442b, doi:10.1039/d3lc00442b. This article has 2 citations and is from a domain leading peer-reviewed journal.

9. (thavandiran2019designofhuman pages 112-118): N Thavandiran. Design of human pluripotent stem cell-derived cardiac microtissue-based platforms for functional screening. Unknown journal, 2019.

10. (thavandiran2019designofhuman pages 118-127): N Thavandiran. Design of human pluripotent stem cell-derived cardiac microtissue-based platforms for functional screening. Unknown journal, 2019.

11. (thavandiran2019designofhuman pages 127-139): N Thavandiran. Design of human pluripotent stem cell-derived cardiac microtissue-based platforms for functional screening. Unknown journal, 2019.
